INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,730,662 | -22.2% | 52,422 | -5.4% | 0.01% | -16.7% |
| Q2 2023 | $3,509,891 | +16.9% | 55,431 | 0.0% | 0.01% | +9.1% |
| Q1 2023 | $3,001,589 | +2.3% | 55,431 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $2,933,409 | +18.9% | 55,431 | +4.6% | 0.01% | +10.0% |
| Q3 2022 | $2,467,000 | -18.5% | 53,010 | 0.0% | 0.01% | -9.1% |
| Q2 2022 | $3,026,000 | -6.7% | 53,010 | 0.0% | 0.01% | +10.0% |
| Q1 2022 | $3,244,000 | -11.1% | 53,010 | -24.0% | 0.01% | -9.1% |
| Q4 2021 | $3,650,000 | +6.8% | 69,728 | -23.9% | 0.01% | 0.0% |
| Q3 2021 | $3,418,000 | +25.8% | 91,672 | +37.7% | 0.01% | +22.2% |
| Q2 2021 | $2,718,000 | +25.7% | 66,586 | +4.5% | 0.01% | +12.5% |
| Q1 2021 | $2,163,000 | -17.2% | 63,743 | -22.4% | 0.01% | -11.1% |
| Q4 2020 | $2,612,000 | +21.4% | 82,133 | -2.0% | 0.01% | 0.0% |
| Q2 2020 | $2,152,000 | +177.3% | 83,840 | +34.1% | 0.01% | +200.0% |
| Q2 2017 | $776,000 | -23.6% | 62,500 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $1,016,000 | +7.7% | 62,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $943,000 | -1.0% | 62,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $953,000 | -60.7% | 62,500 | 0.0% | 0.00% | -63.6% |
| Q2 2016 | $2,426,000 | +39.6% | 62,500 | 0.0% | 0.01% | +37.5% |
| Q1 2016 | $1,738,000 | -74.2% | 62,500 | -50.0% | 0.01% | -42.9% |
| Q4 2015 | $6,724,000 | +168.6% | 125,000 | +100.0% | 0.01% | +27.3% |
| Q3 2015 | $2,503,000 | +74.1% | 62,500 | +38.9% | 0.01% | +83.3% |
| Q2 2015 | $1,438,000 | +33.8% | 45,000 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $1,075,000 | +35.4% | 45,000 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $794,000 | +28.7% | 45,000 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $617,000 | -18.7% | 45,000 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $759,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |